These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8455045)

  • 1. Selection to postmenopausal therapy by women's characteristics.
    Hemminki E; Malin M; Topo P
    J Clin Epidemiol; 1993 Mar; 46(3):211-9. PubMed ID: 8455045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records.
    Lancaster T; Surman G; Lawrence M; Mant D; Vessey M; Thorogood M; Yudkin P; Daly E
    J Epidemiol Community Health; 1995 Aug; 49(4):389-94. PubMed ID: 7650462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of hormone therapy among women with hysterectomy/oophorectomy.
    Chen L; Mishra GD; Dobson AJ; Wilson LF; Jones MA
    Hum Reprod; 2017 Apr; 32(4):885-892. PubMed ID: 28184451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.
    Lambert LJ; Straton JA; Knuiman MW; Bartholomew HC
    J Epidemiol Community Health; 2003 Apr; 57(4):294-300. PubMed ID: 12646547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of postmenopausal hormone therapy and risk of Alzheimer's disease in Finland: nationwide case-control study.
    Savolainen-Peltonen H; Rahkola-Soisalo P; Hoti F; Vattulainen P; Gissler M; Ylikorkala O; Mikkola TS
    BMJ; 2019 Mar; 364():l665. PubMed ID: 30842086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
    Speroff L
    Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
    Parazzini F;
    Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.
    Nabulsi AA; Folsom AR; White A; Patsch W; Heiss G; Wu KK; Szklo M
    N Engl J Med; 1993 Apr; 328(15):1069-75. PubMed ID: 8384316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health behaviors and other characteristics of women on hormone therapy: results from the Third National Health and Nutrition Examination Survey, 1988-1994.
    Brennan RM; Crespo CJ; Wactawski-Wende J
    Menopause; 2004; 11(5):536-42. PubMed ID: 15356406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
    Rossouw JE; Prentice RL; Manson JE; Wu L; Barad D; Barnabei VM; Ko M; LaCroix AZ; Margolis KL; Stefanick ML
    JAMA; 2007 Apr; 297(13):1465-77. PubMed ID: 17405972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women's knowledge of and attitudes towards hormone replacement therapy.
    Lewin KJ; Sinclair HK; Bond CM
    Fam Pract; 2003 Apr; 20(2):112-9. PubMed ID: 12651782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of hormone replacement therapy in 1976-89 by 45-64 year old Finnish women.
    Topo P; Klaukka T; Hemminki E; Uutela A
    J Epidemiol Community Health; 1991 Dec; 45(4):277-80. PubMed ID: 1795146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's health in midlife: the influence of the menopause, social factors and health in earlier life.
    Kuh DL; Wadsworth M; Hardy R
    Br J Obstet Gynaecol; 1997 Aug; 104(8):923-33. PubMed ID: 9255084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmenopausal hormone therapy and migraine headache.
    Misakian AL; Langer RD; Bensenor IM; Cook NR; Manson JE; Buring JE; Rexrode KM
    J Womens Health (Larchmt); 2003 Dec; 12(10):1027-36. PubMed ID: 14709191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis.
    Waaseth M; Bakken K; Dumeaux V; Olsen KS; Rylander C; Figenschau Y; Lund E
    BMC Womens Health; 2008 Jan; 8():1. PubMed ID: 18194511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities.
    Derby CA; Hume AL; Barbour MM; McPhillips JB; Lasater TM; Carleton RA
    Am J Epidemiol; 1993 May; 137(10):1125-35. PubMed ID: 8317442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
    Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
    Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal hormone replacement therapy: scientific review.
    Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
    JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
    Barber CA; Margolis K; Luepker RV; Arnett DK
    J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.